IL-28A Human Uncoated ELISA Kit with Plates - Invitrogen

Capture Antibody: Pre-titrated, purified antibodyDetection Antibody: Pre-titrated, biotin-conjugated antibodyStandard: Recombinant protein for generating standard curve and calibrating samples10X Coating Buffer: Buffer for plating the Capture Antibody5X ELISA/ELISPOT Diluent: Buffer for blocking and diluting the Detection Antibody and EnzymeEnzyme: Pre-titrated Avidin-HRPSubstrate: 1X TMB SolutionCertificate of Analysis: Lot-specific instructions for dilution of antibodies and standards96 Well Plate: Corning Costar 9018 (included with product Cat. Nos. ending in suffixes -22, -76, -86) Cytokine Zcyto20, IFN-lambda-2, Interleukin-28A, IL-28A, Interferon lambda-2, interferon, lambda 2, interferon-lambda 2, interleukin 28A (interferon, lambda 2) About This Kit The Human Interleukin 28A (IL-28A) Uncoated ELISA Kit contains pre-matched antibody pairs ,plates, and reagents for performing quantitative enzyme linked immunosorbent assays (ELISA) to detect and quantify protein levels of human IL-28A. Wash Buffer and Stop Solution are needed to complete the ELISA reaction and are sold separately.Principle of the methodELISAs are designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody is coated to the bottom of the wells of a microplate, which is an overnight process. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. A sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. IL-28A belongs to the IFN lambda family, a novel family of cytokines within the IL-10 superfamily. The three members of this family are IL-29 (IFN lambda 1), IL-28A (IFN lambda 2), and IL-28B (IFN lambda 3), and are also known as the type III Interferons.The IFN lambdas signal through a heterodimeric receptor of which one subunit, IL-10R2, is shared with other members of the superfamily. The second subunit, IFN lambda R1 or IL-28R alpha, is unique to the IFN lambdas. Signaling occurs through the Jak/STAT pathway in a similar manner as the type I IFN (IFN alpha/beta) and activates many of the same genes despite low sequence homology between the cytokines and receptors in the two families. Both IFN families display antiviral activity through the induction of antiviral protein production in target cells and the upregulation of MHC class I expression. These proteins also exhibit antiproliferative and antitumor effects, making them a possible alternative to IFN alpha cancer therapies. Unlike the type I IFN, which are able to stimulate most cells, response to IFN lambda stimulation appears to be limited to dendritic and some tumor cells due to the limited expression of IFN lambda R1. Another notable difference is the ability of the IFN lambda stimulation to drive dendritic cells towards the production of CD4+CD25+FoxP3+ regulatory T cells, suggesting a possible immunoregulatory role For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization. Have you cited this product in a publication? Let us know so we can reference it here. Cite this product Host server : magellan-srch-3-prod-green:8080/10.253.228.100:8080. git-commit: 2cd8645d2fc6bfe4ccb4abfa14772b0a94f68e98 git-url: http://victoria.invitrogen.com:8333/magellan/core.git git-branch: origin/release/1.27.0-2021.08.32-1.0